DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Sledge jr. GW, Toi M, Neven P. et al.
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.
J Clin Oncol 2017;
35: 2875-2884
doi:10.1200/JCO.2017.73.7585
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.